Phase 4 Study Accessing Patient Satisfaction and Tear Osmolarity While Using Blink Tears, Blink Gel Tears and Systane Balance

Ophthalmic Consultants of Connecticut1 site in 1 country60 target enrollmentMay 2012

ConditionsDry Eye

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Dry Eye
Sponsor: Ophthalmic Consultants of Connecticut
Enrollment: 60
Locations: 1
Primary Endpoint: Primary efficacy variable is tear osmolarity
Last Updated: 14 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a single center clinical study designed to determine patient satisfaction and the effect of the use of artificial tears on tear osmolarity with time after instillation of three commercially available artifical tear eye solutions ( Blink Tears, Blink Gel Tears and Systane Balance).

Detailed Description

Patient satisfaction and tear osmolarity with the use of Blink Tears, Blink Gel Tears and Systane Balance.

Registry

clinicaltrials.gov

Start Date

May 2012

End Date

October 2012

Last Updated

14 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Ophthalmic Consultants of Connecticut

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•male or femal subjects (aged 18 or older)
•diagnosed with mild to moderate dry eye syndrome
•provide written informed consent and sign/date a health information release
•women of childbreaing potential must be willing to practice effective contraception for the duration of the study.

Exclusion Criteria

•have any active ocular disease other than mild to moderate dry eye sundrome that would interfere with study interpretation
•active ocular allergy in any eye
•history of or active ocular infection/inflammation
•concomitant use of contact lenses (unilateral or bilateral)
•history of any corneal refractive laser surgery (e.g., LASIK, LASEK, RK,PRK) in the study eye (s);
•corneal disorder or abnormality that affects cornea sensitivity or normal spreading of the tear film in any eye.
•history of any intaocular surgery or glaucoma laser surgery (e.g., ALT, SLT) in the study eye (s)
•known sensitivity or allergy to any of the study medications or their components;
•uncontrolled systemic disease;
•contraindication to pupil dilation;